Stocklytics Platform
Asset logo for symbol BRKR
Bruker
BRKR60
$64.75arrow_drop_up1.61%$1.03
Asset logo for symbol BRKR
BRKR60

$64.75

arrow_drop_up1.61%
Key Stats
Open$64.05
Prev. Close$63.72
EPS2.73
Dividend$0.20
Next Earnings DateSep 19, 2024
Dividend Yield %0.31%
Market Cap$9.73B
PE Ratio23.72
LOWHIGH
Day Range63.82
65.49
52 Week Range53.79
94.86
Ratios
P/B Ratio8.75
Revenue$2.96B
Operating M. %11.00%
Earnings$427.20M
Earnings Growth %43.12%
EBITDA Margin %18.95%
ROE %30.29%
EPS2.73
Fundamentals
RPS$20.55
Gross Profit$1.51B
EBITDA$564.90M
Total Debt$1.48B
P/S Ratio4.0x
Enterprise to EBITDA19.16
Profit Margin13.38%
ROA6.61%
Debt/Equity Ratio1.02%
Payout Ratio7.78%
Industry average yield3.06%
Last Dividend pay dateJun 17, 2024
Dividend per share$0.20
Dividend yield forecast0.00%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

BRKRarrow_drop_down1.59%
US Healthcare Sectorarrow_drop_up0.50%
US Marketarrow_drop_down0.08%
warning
BRKR / Market
BRKR lose to the US Market which returned -0.08% over the last twenty four hours.
warning
BRKR / Healthcare Sector
BRKR lose to the US Healthcare sector which returned 0.50% over the last twenty four hours.

Bruker (BRKR) Statistics

Bruker Corp (BRKR) is a company that specializes in the development and manufacturing of scientific instruments and analytical tools. As a leader in the industry, Bruker Corp provides innovative solutions to scientists and researchers worldwide. With a focus on advancing scientific knowledge and improving human health, the company has established itself as a trusted provider of cutting-edge technologies.

When it comes to stock statistics, Bruker Corp (BRKR) has shown impressive performance. With a market capitalization of over $9 billion, the company's stock has performed well compared to its sector. In terms of valuation metrics, Bruker Corp has a price-to-earnings ratio of 42.52, indicating that the stock may be slightly overvalued. However, the company's strong fundamentals, including a healthy profit margin and low total debt, make it an attractive investment option for many investors.

add Bruker to watchlist

Keep an eye on Bruker

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How much debt does Bruker (BRKR) have?

Bruker (BRKR) has a total debt of $1.48B. The net debt, which accounts for cash and cash equivalents against the total debt, is $1.12B.

help
How has Bruker (BRKR) stock's performance compared to its sector and the market over the past year?

Over the past year, Bruker (BRKR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.49%, Bruker has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 52.38%, it has fallen short of the market average. This comparison highlights Bruker's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of Bruker (BRKR) stock?

The PE (Price to Earnings) ratio of Bruker (BRKR) is currently 23.72. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

help
What is the EPS of Bruker (BRKR) stock?

The Earnings Per Share (EPS) for Bruker (BRKR), calculated on a diluted basis, is $2.73. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of Bruker (BRKR) stock?

The operating margin for Bruker (BRKR) is 11%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of Bruker (BRKR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Bruker (BRKR) is $564.9M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level